Abstract
Amongst all currently used drugs in the field of cancer therapy, the most prominent group of agents which induce DNA, damage both directly or indirectly. Intuitively DNA should not be a perfect target for relatively unspecific small molecular weight drugs. However, the current understanding is that not damage per se but cellular response to DNA damage induced by antitumor agents is responsible for their specific targeted effect towards cancer cells in comparison to the normal cells. DNA damaging chemotherapeutics include compounds with diferent activities namely: directly or indirectly induce DNA strand breaks, covalently modify DNA bases, change the chromatin structure and topology by inhibiting chromatin-modifying enzymes. In this special issue of Current Medicinal Chemistry entitled....
Current Medicinal Chemistry
Title:Editorial: DNA Damage as a Strategy for Anticancer Chemotherapy
Volume: 24 Issue: 15
Author(s): Maria Bozko, Andrzej Bozko, Tim Scholta, Nisar P. Malek and Przemyslaw Bozko*
Affiliation:
- Department of Internal Medicine I, Eberhard Karls University Tubingen Tubingen,Germany
Abstract: Amongst all currently used drugs in the field of cancer therapy, the most prominent group of agents which induce DNA, damage both directly or indirectly. Intuitively DNA should not be a perfect target for relatively unspecific small molecular weight drugs. However, the current understanding is that not damage per se but cellular response to DNA damage induced by antitumor agents is responsible for their specific targeted effect towards cancer cells in comparison to the normal cells. DNA damaging chemotherapeutics include compounds with diferent activities namely: directly or indirectly induce DNA strand breaks, covalently modify DNA bases, change the chromatin structure and topology by inhibiting chromatin-modifying enzymes. In this special issue of Current Medicinal Chemistry entitled....
Export Options
About this article
Cite this article as:
Bozko Maria , Bozko Andrzej , Scholta Tim , Malek P. Nisar and Bozko Przemyslaw *, Editorial: DNA Damage as a Strategy for Anticancer Chemotherapy, Current Medicinal Chemistry 2017; 24 (15) . https://dx.doi.org/10.2174/092986732415170630115722
DOI https://dx.doi.org/10.2174/092986732415170630115722 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Mechanism and Inhibition of Matrix Metalloproteinases
Current Medicinal Chemistry Pharmacodynamics of Memantine: An Update
Current Neuropharmacology Lipid Oxidation Products in the Pathogenesis of Inflammation-related Gut Diseases
Current Medicinal Chemistry Extensive Phytochemistry, Comprehensive Traditional Uses, and Critical Pharmacological Profile of the Great Mullein: Verbascum thapsus L
The Natural Products Journal Translational Multimodality Neuroimaging
Current Drug Targets miRNAs in the Biology of Cancers and Viral Infections
Current Medicinal Chemistry Citicoline and Retinal Ganglion Cells: Effects on Morphology and Function
Current Neuropharmacology Current Issues in Tumor Immunology
Current Bioinformatics Extrahepatic Targets and Cellular Reactivity of Drug Metabolites
Current Medicinal Chemistry Modulation of Histone Acetylation by Garlic Sulfur Compounds
Anti-Cancer Agents in Medicinal Chemistry Role of α -Crystallin B in Regulation of Stress Induced Cardiomyocyte Apoptosis
Cardiovascular & Hematological Agents in Medicinal Chemistry Novel Anthraquinone Derivatives as Dual Inhibitors of Topoisomerase 2 and Casein Kinase 2: In Silico Studies, Synthesis and Biological Evaluation on Leukemic Cell Lines
Anti-Cancer Agents in Medicinal Chemistry Prodrugs for Nitroreductase Based Cancer Therapy- 1: Metabolite Profile, Cell Cytotoxicity and Molecular Modeling Interactions of Nitro Benzamides with Ssap-NtrB
Medicinal Chemistry ATTEMPTS System: A Macromolecular Prodrug Strategy for Cancer Drug Delivery
Current Pharmaceutical Design Syntheses and Cytotoxicity Screening of Some Novel 1,2,4-Triazine Derivatives against Liver Carcinoma Cell Lines
Letters in Organic Chemistry Cathelicidins: Peptides with Antimicrobial, Immunomodulatory, Anti- Inflammatory, Angiogenic, Anticancer and Procancer Activities
Current Protein & Peptide Science Cyclin-Dependent Kinase Inhibitors: Cancer Killers to Neuronal Guardians
Current Medicinal Chemistry Parametric MR Dynamic Imaging for Breast Lesions Characterization and Prediction of Lymph Nodes Involvement
Current Radiopharmaceuticals Design of Magnetic Nanoparticles-Assisted Drug Delivery System
Current Pharmaceutical Design Animal Models for Studying Neointima Formation
Current Vascular Pharmacology